RMEA Stock Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for RMEA from our risk checks.
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.60 |
| 52 Week High | US$21.60 |
| 52 Week Low | US$12.70 |
| Beta | 0.67 |
| 1 Month Change | -5.14% |
| 3 Month Change | -6.21% |
| 1 Year Change | -16.16% |
| 3 Year Change | -3.49% |
| 5 Year Change | 81.42% |
| Change since IPO | 401.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| RMEA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.6% | 2.1% | 0.5% |
| 1Y | -16.2% | -8.4% | 1.3% |
Return vs Industry: RMEA underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: RMEA underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| RMEA volatility | |
|---|---|
| RMEA Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RMEA has not had significant price volatility in the past 3 months.
Volatility Over Time: RMEA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 10,140 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. Fundamentals Summary
| RMEA fundamental statistics | |
|---|---|
| Market cap | €25.16b |
| Earnings (TTM) | €830.02m |
| Revenue (TTM) | €4.20b |
30.3x
P/E Ratio6.0x
P/S RatioIs RMEA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMEA income statement (TTM) | |
|---|---|
| Revenue | US$4.50b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$2.52b |
| Other Expenses | US$1.63b |
| Earnings | US$890.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.06 |
| Gross Margin | 55.86% |
| Net Profit Margin | 19.77% |
| Debt/Equity Ratio | 27.4% |
How did RMEA perform over the long term?
See historical performance and comparison